Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002952120 | SCV003694619 | uncertain significance | Inborn genetic diseases | 2022-01-26 | criteria provided, single submitter | clinical testing | The c.2129G>A (p.C710Y) alteration is located in exon 15 (coding exon 14) of the TRIP12 gene. This alteration results from a G to A substitution at nucleotide position 2129, causing the cysteine (C) at amino acid position 710 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003140199 | SCV003821501 | uncertain significance | Clark-Baraitser syndrome | 2020-04-09 | criteria provided, single submitter | clinical testing |